Open-Label Absorption, Distribution, Metabolism, Excretion (ADME) and Pharmacokinetics (PK) Following a Single Oral Dose of AZD1236 in Healthy Male Subjects
NCT01007929 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 4
Last updated 2009-11-20
Summary
The purpose of this study is to characterise the metabolism, excretion and pharmacokinetics of a single oral dose of \[14C\] AZD1236 in healthy male subjects.
Conditions
- Healthy
Interventions
- DRUG
-
14C-AZD1236
Oral solution 1mg/mL
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
AstraZeneca CPU Medical Director · AstraZeneca
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 50 Years
- Max Age
- 65 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-10-31
- Completion
- 2009-11-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
A Study to Assess the Pharmacokinetics, Metabolism and Excretion Routes of ASP3652 in Man, After Administration of 14C Radio Labeled ASP3652
NCT02046798 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
NCT01442831 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacokinetics Study of Radioactive-Labeled GDC-0973 in Healthy Male Volunteers
NCT01711762 ·Status: COMPLETED ·Phase: PHASE1
-
Absolute Bioavailability and ADME Study of [14C]AZD9977 in Healthy Male Subjects
NCT04686591 ·Status: COMPLETED ·Phase: PHASE1
-
Absorption, Metabolism, Excretion and Absolute Bioavailability
NCT03250039 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Mass Balance and ADME of [14C]AZD5004 and the Absolute Bioavailability of AZD5004
NCT06857695 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Designed to Assess the Mass Balance Recovery, Absorption, Metabolism, Excretion of [14C]AZD5462 and the Absolute Bioavailability of AZD5462
NCT06989983 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of The Excretion Balance, Pharmacokinetics and Metabolism of A Single Oral Dose of [14C]-Labeled RO4917523 in Healthy Male Volunteers
NCT01592890 ·Status: COMPLETED ·Phase: PHASE1
-
A Single-center Study to Investigate How Quickly and to What Extent a Radioactive Dose of RO5285119 is Absorbed, Metabolized and Eliminated From the Body of Healthy Male Volunteers
NCT02179866 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Investigating [14C]-Labeled RO7269162 in Healthy Male Participants
NCT06733298 ·Status: COMPLETED ·Phase: PHASE1
-
Absorption, Distribution, Metabolism and Excretion (ADME) Study With Single Oral Administration of [14C] NKTR-118
NCT01348724 ·Status: COMPLETED ·Phase: PHASE1
-
Excretion of Radiolabelled AZD0837
NCT00812643 ·Status: COMPLETED ·Phase: PHASE1
-
Absorption, Metabolism and Excretion (AME) of Single Dose Radiolabeled BVD-523 in Volunteers
NCT02994732 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Absorption, Metabolism, and Excretion of [14C]-AMG 510 Following a Single Oral Dose in Healthy Male Subjects
NCT05578859 ·Status: COMPLETED ·Phase: PHASE1
-
Adsorption, Metabolism and Excretion (AME) of Single Dose Radiolabeled SPD557 in Volunteers
NCT01786876 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of (14C) Radiolabeled JNJ-56136379 in Healthy Male Participants
NCT03864601 ·Status: COMPLETED ·Phase: PHASE1
-
Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-MD1003 in Healthy Male Subjects
NCT04223232 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How BI 1569912 is Processed in the Body
NCT06520553 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Absorption, Distribution, Metabolism and Excretion (ADME) of [14C]-Pitolisant in Healthy Male Volunteers
NCT02929342 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Pharmacokinetics of ASP015K in Healthy Male Subjects
NCT01406132 ·Status: COMPLETED ·Phase: PHASE1
-
Mass Balance and Pharmacokinetics of [14C]-CRN00808 in Healthy Volunteers
NCT04246749 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Absorption, Metabolism, and Routes of Excretion Following Oral Administration of (14C) Radiolabeled JNJ--42756493 to Healthy Male Participants
NCT02692677 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Effect of AZD5055 on the Pharmacokinetics (PK) of Nintedanib in Healthy Participants.
NCT05644600 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C]-EDG-7500
NCT06738836 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I, Open-Label Trial to Assess the Absorption, Metabolism, and Excretion of (14C)-OPC-61815 in Healthy Male Japanese Subjects
NCT04182958 ·Status: COMPLETED ·Phase: PHASE1